Abstract #0076

In vivo methemoglobin modulation as an intravascular contrast agent for magnetic resonance imaging: Rabbit Model with T1 measurement

Seong-Eun Kim¹, J Scott McNally¹, Matthew Alexander¹, Dennis L Parker¹, Matthew S Zabriskie ¹, and Ronald Day²

¹UCAIR, Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, United States, ²Department of Pediatrics, University of Utah, Salt Lake City, UT, United States

After intravenous injection, gadolinium(GBCA), commonly used for MR contrast, distributes from intravascular to the extravascular space and rapidly cleaned by renal excretion. This pharmacologic behavior makes GBCA unfavorable as in blood pool agent. One potential alternative agent is endogenous intracellular methemoglobin (MetHb), a paramagnetic molecule in our blood cells. Intracellular levels of MetHb can be increased by exposing blood to sodium nitrite. We evaluated change of T1 of blood according to a transient increase in intracellular MetHb in in vivo animal model. Our results demonstrated that MetHb modulation resulted T1 shortening of blood and soft tissue enhancement.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.